U.S. FDA Approves Additional Presentation of Celltrion’s Stelara Biosimilar
The U.S. Food and Drug Administration (FDA) has approved a new presentation of Celltrion, Inc’s Stelara (ustekinumab) biosimilar.
Day: June 16, 2025
The U.S. Food and Drug Administration (FDA) has approved a new presentation of Celltrion, Inc’s Stelara (ustekinumab) biosimilar.